| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $40.52M | $32.31M | $78.12M | $19.71M | $25.54M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $200.53M | $283.47M | $247.30M | $245.66M | $218.69M |
| R&D | $89.95M | $199.25M | $177.65M | $174.96M | $142.51M |
| SG&A | $49.90M | $71.99M | $69.65M | $70.70M | $76.18M |
| Operating Income | -$160.01M | -$251.15M | -$169.18M | -$225.95M | -$193.15M |
| Interest Expense | $6.17M | $2.13M | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$160.06M | -$237.09M | -$153.22M | -$220.43M | -$192.50M |
| EPS (basic) | -1.8000 | -2.8800 | -2.0200 | -3.2100 | -2.8500 |
| EPS (diluted) | -1.8000 | -2.8800 | -2.0200 | -3.2100 | -2.8300 |
| Shares (diluted) | $88.75M | $82.34M | $75.97M | $68.66M | $67.62M |